Peter Tyrer

ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies

Francesca Zammarchi, Simon Corbett, Lauren Adams et al. · Blood · 2018 · 181 citations · Full text

Pharmacy, Oncology, Pharmaceutics +13

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer–Containing Antibody–Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies

Michael Flynn, Francesca Zammarchi, Peter Tyrer et al. · Molecular Cancer Therapeutics · 2016 · 127 citations · Full text

Medicine, Oncology, Pharmacology +17

Microbial Pattern Recognition Receptors Mediate M-Cell Uptake of a Gram-Negative Bacterium

Peter Tyrer, A. Ruth Foxwell, Allan W. Cripps et al. · Infection and Immunity · 2005 · 96 citations · Full text

Life Sciences, Cell Biology, Microbiology +11

Validation and quantitation of an in vitro M-cell model

Peter Tyrer, A. Ruth Foxwell, Jennelle M. Kyd et al. · Biochemical and Biophysical Research Communications · 2002 · 50 citations · Full text

Life Sciences, Cell Biology, Cell Physiology +6

Escherichia coli-derived outer membrane vesicles are genotoxic to human enterocyte-like cells

Peter Tyrer, Frank Frizelle, Jacqueline I. Keenan · Infectious Agents and Cancer · 2014 · 47 citations · Full text

Medicine, Cell Biology, Microbiology +15